Partnership to accelerate enrollment and diversity in neurovascular clinical research SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic partnership with Vastrax, the leading full-service, vascular clinical research organization (CRO). Together, Viz.ai and Vastrax will accelerate clinical trial enrollment for research on novel […]
Neuro
Announcing the launch of Medtronic Neurovascular Co-Lab™ Platform to accelerate innovation in stroke treatment
New Medtronic Neurovascular Co-Lab™ Platform drives collaboration and connections among start-ups, physicians, and institutions; aims to improve stroke treatment and access for patients worldwide DUBLIN, Oct. 26, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the launch of Medtronic Neurovascular Co-Lab™ Platform designed to accelerate urgently needed innovation […]
Mentice and Acandis GmbH announce a 3-year agreement for Mentice Ankyras clinical support software solutions at a value of 8.9mSEK
Sweden–Gothenburg and Germany-Pforzheim, October 25, 2022 (https://news.cision.com/mentice-ab). GOTHENBURG, Sweden, Oct. 25, 2022 /PRNewswire/ — Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Acandis, Pforzheim, a leading innovator of minimal invasive devices for the treatment of neurovascular diseases, has signed a 3-year collaboration agreement to further develop the Acandis […]
New Initiative to Prevent, Treat and Beat Stroke Focuses on Health Equity, Heart-brain Connection
The American Heart Association’s Getting to the Heart of Stroke™ initiative, developed in conjunction with and supported by HCA Healthcare and the HCA Healthcare Foundation, focuses on preventing, treating and beating stroke by providing consumer and health care professional education nationwide, deepening collaboration between neurology and cardiology and equitably empowering communities […]
Shady Grove Medical Center Earns Certification in Breakthrough Stroke Treatment from The Joint Commission
ROCKVILLE, Md., Oct. 4, 2022 /PRNewswire/ — Adventist HealthCare Shady Grove Medical Center has earned national certification for mechanical thrombectomy, a minimally invasive surgical treatment for stroke that studies show can improve outcomes for many patients. Shady Grove Medical Center attained Thrombectomy-Capable Stroke Center (TSC) Certification from The Joint Commission, in collaboration with the […]
MicroVention Celebrates 25 Years in Neuroendovascular Technologies that Improve Patient Lives
ALISO VIEJO, Calif., Sept. 29, 2022 /PRNewswire/ — MicroVention, Inc., a global neurovascular company and a wholly owned subsidiary of Terumo Corporation, celebrates its 25-year anniversary on September 29, 2022. Founded in 1997 by a handful of Associates in a small facility in Southern California, MicroVention is now a worldwide community with over 3,000 […]
Acticor Biotech Announces the Enrollment of the First US Patient in its Phase 2/3 Study ACTISAVE for the Treatment of Stroke
PARIS–(BUSINESS WIRE)–ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT) (Paris:ALACT), a clinical-stage biotechnology company developing innovative drugs for the treatment of cardiovascular emergencies, particularly stroke, today announced the enrollment of the first patient in the USA in its Phase 2/3 registration study ACTISAVE, which is evaluating glenzocimab in patients with acute ischemic […]
GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)
Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of target enrollment (948 patients). The independent data monitoring committee (IDMC) has completed interim analysis and indicated that the trial should continue. The […]
Corindus, A Siemens Healthineers Company, Announces Study Results Demonstrating Safety and Effectiveness of CorPath® GRX Neurovascular System
Study marks world’s first trial on robotic-assisted neurovascular aneurysm embolization NEWTON, Mass.–(BUSINESS WIRE)–Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today it presented the results of a first-of-its-kind study demonstrating the safety and effectiveness of robotic-assisted neurovascular aneurysm embolization using the CorPath GRX Neurovascular […]
RapidAI Applauded by Frost & Sullivan for Delivering Quality Care Quickly and Securely With Its RapidAI Platform
The fast, accurate, and proven RapidAI platform improves patient and staff experience and diagnostic accuracy, ensures high care team coordination, better health outcomes, and reduces costs. SAN ANTONIO, Sept. 12, 2022 /PRNewswire/ — Frost & Sullivan recently analyzed the artificial intelligence (AI) algorithms for the stroke market, and, based on its assessment results, recognizes RapidAI with […]
